Stay updated on Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial page.

Latest updates to the Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page footer now shows a newer ClinicalTrials.gov site revision (v3.5.3) instead of the previous revision (v3.5.0). This reflects a platform/version update rather than a change to the clinical trial information presented.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedRevision history updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedThe updates include a minor footer revision (v3.4.2) and removal of an older funding-status notice; no changes to trial details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedAdded a site-wide notice about government funding lapse and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check100 days agoChange DetectedAdded a glossary toggle label and updated metadata to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The prior wording for QC updates and 'Revision: v3.3.4' has been removed.SummaryDifference0.2%

Stay in the know with updates to Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial page.